Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 58OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 9Observational 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Sarcopenia 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Efficacy, Team 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 7Blood Specimen Collection 7Observation 6Surgical Procedures, Operative 4Radiotherapy 4Drug Therapy 4Physical Examination 3Magnetic Resonance Spectroscopy 3Endoscopic Mucosal Resection 3Echocardiography 3pembrolizumab 2Zoledronic Acid 2Watchful Waiting 2Thyroidectomy 2Standard of Care 2Robotic Surgical Procedures 2Radiosurgery 2Radiation 2Preoperative Exercise 2Population Groups 2Palliative Care 2Nivolumab 2Neoadjuvant Therapy 2Mass Screening 2Laparoscopy 2Immune Checkpoint Inhibitors 2Hematologic Tests 2Granulocyte Colony-Stimulating Factor 2Gastrectomy 2Endoscopic Ultrasound-Guided Fine Needle Aspiration 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Observational × Immune Checkpoint Inhibitors × Clear all
NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Completed
131 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT06693440 2024-11-18

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Henan Cancer Hospital

Recruiting
3,000 enrolled

Efficacy, Team

Data powered by HemOnc (CC BY 4.0) Colophon âš¡